Call Vector Medical Billing
+1 (929) 539-7737
50States
Rheumatology Billing Services
Rheumatology billing is infusion administration and the drug — coded apart from the visit — then prior auth, joint injections with guidance when documented, and DEXA frequency. Vector Medical Billing, in Jamaica, New York, reconciles J-code units and JW/JZ, tracks step therapy, and runs the cycle inside the EHR you already use.
98%Published NCR
24hClaim Submission
BAASigned with every client
AAPCCertified coders
AHIMACertified coders
E&OErrors and omissions insured
50 StatesRemote billing nationwide
Monthly fee
What rheumatology billing services include
Full-cycle RCM for rheumatology clinics and in-office infusion suites — chronic autoimmune care, buy-and-bill biologics, and procedures on one account.
The operating cycle matches medical billing services: eligibility and prior auth, charge capture from infusion records and visit notes, ICD-10 / CPT / HCPCS coding, scrub, clearinghouse submission, payment posting, denial management, and A/R follow-up. The scrub watches drug units vs dose, biosimilar Q-codes, JW/JZ, administration hierarchy and start/stop times, visit-vs-infusion separation, joint size and ultrasound guidance, and DEXA frequency.
In scope: office/outpatient E/M, IV biologic and biosimilar buy-and-bill with administration codes, therapeutic injections when billed in office, joint and soft-tissue arthrocentesis/injection families, musculoskeletal ultrasound when separately reportable, DEXA, and lab-order documentation that supports MDM (while the performing lab usually bills the tests). Dedicated oncology billing covers oncology-specific buy-and-bill suites when that is a separate account — rheumatology infusions stay here. Self-administered specialty pharmacy biologics (Part D / pharmacy benefit) are coordinated, not forced onto the medical claim.
The fee is a percentage of net collections. The written rate is on pricing. Credentialing, a retrospective coding audit, MIPS, and out-of-network / IDR stay separate engagements.
What sits on this rheumatology fee
- Drug, administration, and visit kept on separate lines when the rules require it
- Auth, units, and JW/JZ watched before high-dollar infusions age
- HIPAA workflows, a signed BAA, and PHI limited to staff on the account
Where rheumatology claims fail
Patterns specialty rheum RCM vendors keep naming on biologic and injection days.
Drug collapsed into the visit
High-dollar biologic left off the claim, wrong HCPCS unit math, or auth lapsed mid-course. The visit does not carry the drug — and the drug does not replace a separately documented E/M when one was performed.
NDC, administered units, and waste lines must reconcile before submission.
Step therapy / auth gaps
Infusion given without current prior auth, missing disease-activity scores or failed DMARD history in the packet, or biosimilar not on the payer’s preferred list. Reauthorization dates missed between maintenance doses.
Auth is scrubbed before the chair is booked — not after the vial is opened.
Injection + 25 without a real visit
Planned injection series billed with 25 on a note that only documents the injection. Or 20611 with separate 76942. Permanent US images missing when the with-guidance code is used.
Payers watch rheum same-day E/M + injection combinations closely.
Admin · drug · not the visit
Infusion administration and the drug — apart from the visit
Hub language made operational: three claim stories when all three are real.
Buy-and-bill biologics (infliximab and biosimilars, abatacept, tocilizumab, rituximab, belimumab, and similar) bill by HCPCS unit size — not “per vial” and not “per milligram assumed.” Convert the administered dose to billable units. Report discarded single-dose drug with JW on a separate line, or JZ when none was discarded. Use the correct biosimilar Q-code and NDC for the product actually infused.
Administration uses the therapeutic infusion hierarchy (e.g. 96365 first hour, 96366 each additional when time rules are met) or complex drug administration codes (96413/96415) when the agent and monitoring meet that family. Nursing start/stop times support additional-hour units. Hydration solely to keep the line open is typically bundled — not a separate hydration code beside the biologic.
Infusion-day checklist
- Auth current for drug, dose, and site of care
- Drug units + JW/JZ + NDC reconcile
- Admin codes match documented infusion time; E/M only if separately identifiable
Prior authorization and step therapy
Most biologic dollars die here — before coding ever starts.
What the packet needs
Diagnosis, disease-activity measures (DAS28, CDAI, or payer-equivalent), prior conventional DMARD trials with dates and outcomes, serology when relevant, and the planned dosing. Step therapy must be documented across plan changes when the patient switches coverage.
Renewals and biosimilars
Track auth by drug, cycle, and expiration so maintenance infusions do not run uncovered. Confirm preferred biosimilar lists and non-medical switch rules before substituting products. Site-of-care restrictions (office vs hospital outpatient) belong in the auth, not as a surprise denial.
Joint injections and ultrasound guidance
Joint size, guidance, drug units, and same-day visit rules.
By joint size
Small (20600), intermediate (20605), major (20610) without ultrasound. With ultrasound guidance and permanent images: 20604 / 20606 / 20611. Do not add 76942 to the with-guidance codes.
Steroid / viscosupplement
Corticosteroid and hyaluronic acid products bill with their J-codes and units. Viscosupplementation often has knee-only coverage, frequency caps, and failed conservative-care requirements — check benefits before ordering the product.
Same-day E/M
Modifier 25 only when a significant, separately identifiable evaluation is documented beyond the injection itself. A planned injection-only return typically does not support 25.
DEXA and monitoring labs
Frequency and diagnosis drive coverage; toxicity monitoring supports E/M complexity.
Bone density
77080 / related DEXA codes need LCD-compatible diagnoses (osteoporosis risk, long-term steroid use, and similar) and payer frequency limits. Billing early is a benefit denial. Long-term glucocorticoid patients in rheumatology are a common appropriate indication — document it.
DMARD monitoring
CBC, CMP, and hepatic panels for methotrexate and other DMARDs are usually billed by the performing laboratory. The rheumatologist’s ordered monitoring plan in the note still supports medical decision-making on the E/M — do not invent lab charges the practice does not own.
Rheumatology code families this service works
Illustrative anchors — the infusion record, auth, and payer policy decide the final claim.
| Work type | Example | What to check | Common failure if skipped |
|---|---|---|---|
| Office E/M | 99202–99215 ± 25 | Separate from infusion/injection | Habit-25 on injection-only day |
| Biologic drug | J1745 / Q-biosimilars; J0129; etc. | Units; NDC; product infused | Wrong unit math |
| Waste | JW / JZ | Single-dose vial rules | Missing waste attestation |
| Administration | 96365/96366 or 96413/96415 | Start/stop; hierarchy | Hours without time docs |
| Joint injection | 20600–20611 | Size; US image if guidance | 76942 unbundled |
| Viscosupplement | J732x + 20610/20611 | Coverage; frequency | Non-covered brand billed |
| DEXA | 77080 | LCD diagnosis; interval | Booked too early |
| Self-injectable | Pharmacy / Part D | Not forced on medical claim | SAD exclusion denial |
This page does not invent a rheumatology denial percentage. The free audit reads your unit math, auth gaps, and visit/infusion split on the sample you send.
What a free audit line looks like
Illustrative composite only — not a client result and not a promised recovery.
| Field | Example entry |
|---|---|
| Documented service | RA maintenance infliximab 350 mg infused over 2.5 hours; 50 mg discarded from single-dose vials; separately identifiable flare E/M with DMARD adjustment same day; auth current |
| Billed codes | 99214 only; drug and admin never charged |
| Issue found | Buy-and-bill drug and administration omitted; JW waste not reported; visit alone understates the day |
| Recommended correction | J1745 units for 350 mg + JW for discarded units + admin codes per timed hierarchy + 99214-25 if E/M stands alone |
| Related check | Biosimilar Q-code if biosimilar product was used instead of reference |
| Why it matters | Highest-dollar lines left on the table — caught in scrub or flagged in the free audit |
Request a Free Audit with recent notes, claims, and denials. We map drug, admin, and visit on your file — not this composite.
How Vector runs rheumatology billing
Auth and units first — then the same revenue cycle.
1
Assign rheumatology
Coder and biller who already work biologic units, JW/JZ, and joint-injection guidance.
2
Reconcile and code
Charge entry and coding from infusion and visit records — queries when dose or time cannot be supported.
4
Post and report
835 posting, denial work, A/R aging, monthly RCM report by visit vs drug vs procedure.
Not inside the rheumatology percentage
Related work stays separate so the quote matches the job.
Self-injectable pharmacy
Home self-administered biologics usually ride Part D or specialty pharmacy — not buy-and-bill on the medical claim. We coordinate benefits investigation; we do not force SAD-list drugs onto Part B.
Credentialing / audit
Credentialing and a retrospective coding audit of infusion units are separate engagements when scoped.
Underpay / OON
Underpayment recovery and OON / IDR stay separate when the dispute path is not ordinary denial work.
How rheumatology billing is priced
Percentage of dollars that land — not a flat fee per infusion that ignores unit and auth leaks.
Written rate
The fee is a percentage of net collections. No setup fee on the monthly cycle. Month to month. The written rate follows visit and infusion volume, drug mix, and how much of the cycle you hand over.
See pricing or request a written rate after the free audit.
What we need to start
EHR access, monthly visit and infusion census, drug formulary mix, open A/R if you are leaving another biller, and a sample of recent biologic or injection denials. Switching usually overlaps so claim submission does not stop. See EHR integration if access setup needs a separate quote.
Audit the rheum claims that bill the visit and lose the drug
Send monthly visit and infusion volume, top biologics, EHR name, and a sample of drug or auth denials. We reply with what the open A/R shows, whether the monthly fee fits, and a written rate — without inventing a clean-claim percentage.
Written
Monthly rate
98%
Published NCR
50
US States
BAA
Every Client
Rheumatology billing questions
Straight answers tied to the sections above.
What does rheumatology billing include?
Clinic E/M, biologic drug and administration apart from the visit, auth/step therapy, joint injections with guidance when documented, DEXA, scrubbing, submission, posting, denials, and A/R.
How much do rheumatology billing services cost?
The fee is a percentage of net collections. No setup fee on the monthly cycle. The written rate follows visit and infusion volume and payer mix.
Are the drug and administration billed apart from the visit?
Yes. Drug units, administration codes, and any separately identifiable E/M are different lines. Do not collapse the biologic into the visit.
How are JW and JZ used?
JW for discarded single-dose drug on a separate line; JZ when none was discarded. Administered units, NDC, and waste must reconcile.
How are ultrasound-guided joint injections billed?
Use the with-guidance code for joint size (e.g. 20611). Save permanent images. Do not also bill 76942. Drug J-codes bill separately.
Do we have to change our EHR?
No. Billers work in the system you already use — see EHR integration. Compatibility is confirmed before you commit.
Where does Vector provide rheumatology billing?
The office is 15717 85th St, Jamaica, NY 11414-2620. Work is remote for rheumatology practices in all 50 states. See the specialties hub.
Is Vector Medical Billing HIPAA certified?
HHS does not certify billing companies. Vector signs a BAA, limits PHI to staff on the account, and follows HIPAA workflows. A HIPAA security risk analysis is a separate engagement when scoped.